Market Research Industry Reports

Bone Biologics Corp (BBLG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Bone Biologics Corp (Bone Biologics) is a developer of orthobiologic products. The company develops NELL-1, a recombinant human protein growth factor which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also offers Nell-1/TCP fusion device, which is a single dose vial of Nell-1 recombinant protein freeze dried onto tricalcium phosphate and demineralized bone putty. The companys technology has application in spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicines. It collaborates with contract manufacturing organizations to develop its products. Bone Biologics is headquartered in Burlington, Massachusetts, the US.

Bone Biologics Corp (BBLG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bone Biologics Corp, Medical Devices Deals, 2012 to YTD 2018 9
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Bone Biologics Raises USD5 Million in Venture Financing 11
Merger 12
AFH Acquisition Merges with Bone Biologics in Reverse Merger Transaction 12
Equity Offering 13
Bone Biologics Raises USD0.5 million in Second Tranche of Financing 13
Bone Biologics Corp - Key Competitors 14
Bone Biologics Corp - Key Employees 15
Bone Biologics Corp - Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Aug 03, 2017: Bone Biologics Announces Appointment of Bret Hankey to Companys Board of Director 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables

List of Tables
Bone Biologics Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Bone Biologics Corp, Medical Devices Deals, 2012 to YTD 2018 9
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bone Biologics Raises USD5 Million in Venture Financing 11
AFH Acquisition Merges with Bone Biologics in Reverse Merger Transaction 12
Bone Biologics Raises USD0.5 million in Second Tranche of Financing 13
Bone Biologics Corp, Key Competitors 14
Bone Biologics Corp, Key Employees 15

List Of Figures

List of Figures
Antitope Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antitope Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Global Bone Graft Industry Market Research Report

The Bone Graft market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of

USD 2960View Report

Global Bone Glues Industry Market Research Report

The Bone Glues market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of

USD 2960View Report

Aperion Biologics Corp - Product Pipeline Analysis, 2017 Update

Aperion Biologics Corp (Aperion Biologics) is a medical device company that develops and commercializes animal-based tissue technology. The companys products include ligament reconstruction. Its Z-Process of humanizing and sterilizing tissue

USD 750View Report

Bone Biologics Corp (BBLG) - Medical Equipment - Deals and Alliances Profile

Bone Biologics Corp (Bone Biologics) is a biotechnology company that develops orthobiologic products. The company develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development.

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :18
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube